SEC Tracker
Get the app

Halozyme Therapeutics HALO

Torley Helen (Officer) plans to sell 10,000 HALO shares, about $525,778

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Oct 9, 2024
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Stock Option Exercise
  4. 10b5-1 plan adopted: Mar 22, 2024

All of Torley Helen's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 5,981 shares at $51.85 on Oct 9, 2024 · Form 4
  • Sold 1,615 shares at $53.31 on Oct 9, 2024 · Form 4
  • Sold 2,404 shares at $53.91 on Oct 9, 2024 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Halozyme Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025
  2. Alkermes ALKS public float $4.7B, Jun 30, 2025
  3. Lantheus Holdings LNTH public float $4.3B, Jun 30, 2025
  4. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  5. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.